SynthesisInfection2024

Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review.

Myriam Drysdale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.